Current Clinical Trials
-
by
mervyn
Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab (VAY RE-HIT)
Link to Clincialtrials.gov page for this trial
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
Link to Clincialtrials.gov page for this trial
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Link to Clincialtrials.gov page for this trial
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Link to Clincialtrials.gov page for this trial
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia (advance NEXT)
Link to Clincialtrials.gov page for this trial
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
Link to Clincialtrials.gov page for this trial
